Novartis: Eyes on Roche stake sale

| Updated on January 20, 2018 Published on April 25, 2016


According to global media, Novartis is discussing options with banks for selling its near $14-billion stake in rival Roche, potentially providing cash for new deals. Novartis built up its one-third stake in Roche’s voting stock between 2001 and 2003 under former chairman and CEO Daniel Vasella, as thebasis for a possible merger that never happened. Shares of Novartis India will also remain in focus, though the deal may not materialise immediately.

Published on April 25, 2016
This article is closed for comments.
Please Email the Editor